Tumor-Specific Cytotoxic T Lymphocyte (Obstetrics & Gynecology Hospital Of Fudan University)

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameTumor-Specific Cytotoxic T Lymphocyte (Obstetrics & Gynecology Hospital Of Fudan University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionCytotoxic T lymphocytes modulators
TargetsNot applicable
Therapy Area/IndicationsGenital Neoplasms, Female
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesObstetrics & Gynecology Hospital Of Fudan University
China Registration ClassN/A

Develop Information

Active CompaniesObstetrics & Gynecology Hospital Of Fudan University
Inactive CompaniesN/A
Active IndicationsGenital Neoplasms, Female
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A